Format

Send to:

Choose Destination
See comment in PubMed Commons below
Eur Urol. 2008 Apr;53(4):845-8. Epub 2007 Nov 20.

Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.

Author information

  • 1Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, QC, Canada. pierre.karakiewicz@umontreal.ca <pierre.karakiewicz@umontreal.ca>

Abstract

A 75-yr-old previously healthy woman presented with gross hematuria, European Cooperative Oncology Group 0, and an 11-cm renal mass with right atrial thrombus. The patient refused the sternotomy. She was offered two cycles of sunitinib maleate (Sutent) induction therapy to down-stage the thrombus and to reduce the extent of the surgery.

PMID:
18053636
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk